Product NDC: | 27808-031 |
Proprietary Name: | Nexiclon XR |
Non Proprietary Name: | Clonidine |
Active Ingredient(s): | .26 mg/1 & nbsp; Clonidine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 27808-031 |
Labeler Name: | Tris Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022500 |
Marketing Category: | NDA |
Start Marketing Date: | 20101217 |
Package NDC: | 27808-031-01 |
Package Description: | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (27808-031-01) |
NDC Code | 27808-031-01 |
Proprietary Name | Nexiclon XR |
Package Description | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (27808-031-01) |
Product NDC | 27808-031 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clonidine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101217 |
Marketing Category Name | NDA |
Labeler Name | Tris Pharma, Inc. |
Substance Name | CLONIDINE |
Strength Number | .26 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |